NRXP -MC $50m -Phase 3 results imminent for their bipolar depression drug expected this month and another Phase 3 results from their chronic back pain trial also expected in the coming weeks . With positive results this low floater going to explode toward $20 currently trading at $5.20 .Check out their presentation below for more informations
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.